WHO ICTRP trial

A Pharmaceutico-Analytical Study of Rajat Bhasma, Shankhpushpi syrup and…

CTRI/2018/05/013797 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2018/05/013797
Public title A Pharmaceutico-Analytical Study of Rajat Bhasma, Shankhpushpi syrup and clinical evaluation of Rajat Bhasma with Shankhpushpi syrup as Memory Enhancer i.e. Medhya.
Scientific title A Pharmaceutico-Analytical Study of Rajat Bhasma, Shankhpushpi Syrup and Clinical evaluation of Rajat Bhasma with Shankhpushpi Syrup as Medhya.
Primary sponsor Rajiv Gandhi Govt PG Ayurvedic College Paprola HPR
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Observational
Phase Phase 2
Countries India
Interventions Intervention1: Rajat Bhasma, Shankhpushpi Syrup: Rajat Bhasma 100mg OD Shankhpushpi Syrup 10ml BD with Luke Warm Water
Registration date Sep 5, 2018
Target size 10
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations